A previous report indicated that SARS-CoV-2-reactive CD8+ T cells from convalescent patients with mild COVID-19 were predominantly TEMRA cells expressing CD28, suggesting a protective role (Neidleman et al., 2020). This evidence concerns the gene CD8A and COVID-19.